RNAC
Price
$11.04
Change
+$1.69 (+18.09%)
Updated
Jun 6 closing price
Capitalization
243.45M
TNXP
Price
$40.65
Change
+$2.24 (+5.83%)
Updated
Jun 6 closing price
Capitalization
281.19M
64 days until earnings call
Interact to see
Advertisement

RNAC vs TNXP

Header iconRNAC vs TNXP Comparison
Open Charts RNAC vs TNXPBanner chart's image
Cartesian Therapeutics
Price$11.04
Change+$1.69 (+18.09%)
Volume$100.18K
Capitalization243.45M
Tonix Pharmaceuticals Holding
Price$40.65
Change+$2.24 (+5.83%)
Volume$729.08K
Capitalization281.19M
RNAC vs TNXP Comparison Chart
Loading...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RNAC vs. TNXP commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNAC is a Buy and TNXP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (RNAC: $9.09 vs. TNXP: $37.69)
Brand notoriety: RNAC and TNXP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNAC: 89% vs. TNXP: 95%
Market capitalization -- RNAC: $243.45M vs. TNXP: $281.19M
RNAC [@Biotechnology] is valued at $243.45M. TNXP’s [@Biotechnology] market capitalization is $281.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNAC’s FA Score shows that 0 FA rating(s) are green whileTNXP’s FA Score has 2 green FA rating(s).

  • RNAC’s FA Score: 0 green, 5 red.
  • TNXP’s FA Score: 2 green, 3 red.
According to our system of comparison, TNXP is a better buy in the long-term than RNAC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNAC’s TA Score shows that 5 TA indicator(s) are bullish while TNXP’s TA Score has 4 bullish TA indicator(s).

  • RNAC’s TA Score: 5 bullish, 3 bearish.
  • TNXP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RNAC is a better buy in the short-term than TNXP.

Price Growth

RNAC (@Biotechnology) experienced а -2.05% price change this week, while TNXP (@Biotechnology) price change was +33.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

TNXP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNXP($281M) has a higher market cap than RNAC($243M). RNAC has higher P/E ratio than TNXP: RNAC (1.76) vs TNXP (0.11). TNXP YTD gains are higher at: 14.281 vs. RNAC (-49.246). TNXP has higher annual earnings (EBITDA): -71.73M vs. RNAC (-75.99M). RNAC has more cash in the bank: 213M vs. TNXP (98.8M). TNXP has less debt than RNAC: TNXP (8.12M) vs RNAC (14M). RNAC has higher revenues than TNXP: RNAC (38.9M) vs TNXP (10.1M).
RNACTNXPRNAC / TNXP
Capitalization243M281M86%
EBITDA-75.99M-71.73M106%
Gain YTD-49.24614.281-345%
P/E Ratio1.760.111,633%
Revenue38.9M10.1M385%
Total Cash213M98.8M216%
Total Debt14M8.12M172%
FUNDAMENTALS RATINGS
RNAC vs TNXP: Fundamental Ratings
RNAC
TNXP
OUTLOOK RATING
1..100
564
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9534
P/E GROWTH RATING
1..100
6213
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TNXP's Valuation (28) in the Pharmaceuticals Other industry is significantly better than the same rating for RNAC (99) in the Biotechnology industry. This means that TNXP’s stock grew significantly faster than RNAC’s over the last 12 months.

TNXP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as RNAC (100) in the Biotechnology industry. This means that TNXP’s stock grew similarly to RNAC’s over the last 12 months.

TNXP's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as RNAC (100) in the Biotechnology industry. This means that TNXP’s stock grew similarly to RNAC’s over the last 12 months.

TNXP's Price Growth Rating (34) in the Pharmaceuticals Other industry is somewhat better than the same rating for RNAC (95) in the Biotechnology industry. This means that TNXP’s stock grew somewhat faster than RNAC’s over the last 12 months.

TNXP's P/E Growth Rating (13) in the Pharmaceuticals Other industry is somewhat better than the same rating for RNAC (62) in the Biotechnology industry. This means that TNXP’s stock grew somewhat faster than RNAC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RNACTNXP
RSI
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
79%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bearish Trend 12 days ago
87%
Bullish Trend 12 days ago
82%
MACD
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
89%
Bullish Trend 12 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
88%
Bullish Trend 12 days ago
80%
Advances
ODDS (%)
Bullish Trend about 1 month ago
82%
Bullish Trend 12 days ago
80%
Declines
ODDS (%)
Bearish Trend 18 days ago
88%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bullish Trend 12 days ago
71%
Bullish Trend 12 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

RNAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with WINT. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
+3.65%
WINT - RNAC
94%
Closely correlated
+5.12%
NCNA - RNAC
92%
Closely correlated
-3.85%
NBY - RNAC
91%
Closely correlated
-0.58%
SNPX - RNAC
91%
Closely correlated
-10.74%
SNGX - RNAC
89%
Closely correlated
+1.05%
More

TNXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNXP has been closely correlated with NCNA. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if TNXP jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNXP
1D Price
Change %
TNXP100%
+1.89%
NCNA - TNXP
90%
Closely correlated
-3.85%
SNPX - TNXP
88%
Closely correlated
-10.74%
WINT - TNXP
88%
Closely correlated
+5.12%
RNAC - TNXP
88%
Closely correlated
+3.65%
CDTX - TNXP
87%
Closely correlated
-5.46%
More